English
Back
Download
Log in to access Online Inquiry
Back to the Top

European Morning News but now in evening here 😅

$Novo-Nordisk A/S (NVO.US)$ The European Commission has authorized the acquisition of joint control of ... "Sylvan International Biotechnology" ... , from China, by Novo Nordisk Foundation, from Denmark, and KKR, from the United States. The operation mainly concerns the development and of the production of edible mushroom mycelium.
The Commission concluded that the notified transaction would not raise competition concerns, given that the joint venture has negligible activities in the European Economic Area and that the combined position of companies on the market resulting from the proposed transaction is limited.
Conclusion; an Amazing deal for the Future
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only. Read more
2
+0
Translate
Report
40K Views
Comment
Sign in to post a comment
    Retired investment advisor & Dr.
    356
    Followers
    43
    Following
    1628
    Visitors
    Follow
    Reassessing Chinese Assets
    Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.